Portal de investigación
Long-term effects of elexacaftor/tezacaftor/ivacaftor on clinical outcomes and quality of life among adolescents and adults aged 12+with cystic fibrosis: Interim results from the TRAJECTORY Study
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ratjen, F
- Schwarz, C
- Daccò,
- Duckers, J
- Azevedo, P
- Ahmed, M
- Gamboa, F
- Cipolli, M
- Quon, B
- Do, Q
- Muller, E
- Jennings, M
- Sutharsan, S
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0040-6376, 1468-3296
- Tipo:
- Meeting Abstract
- Páginas:
- 51-52
- Factor de Impacto:
- 2,309 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Thorax BMJ PUBLISHING GROUP
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Ratjen,F,Schwarz,C,Daccò,,Duckers,J,Solé,A,Azevedo,P,Ahmed,M et al. Long-term effects of elexacaftor/tezacaftor/ivacaftor on clinical outcomes and quality of life among adolescents and adults aged 12+with cystic fibrosis: Interim results from the TRAJECTORY Study. Winter Meeting of the British-Thoracic-Society (BTS). 2025. London. BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND:BMJ PUBLISHING GROUP. 2025 p.p. 51-52.